Results from the Phase I/II trials for ChAdOx1 nCoV-19, the vaccine developed by scientists at The University of Oxford’s Jenner Institute and the Oxford Vaccine group, have been published today in scientific journal, The Lancet.
Oxford University's independent newspaper | A new voice for a new decade | Est. 2020..
Results from the Phase I/II trials for ChAdOx1 nCoV-19, the vaccine developed by scientists at The University of Oxford’s Jenner Institute and the Oxford Vaccine group, have been published today in scientific journal, The Lancet.
